再鼎医药 (ZLAB.O)

+ 收藏

财务摘要(报告期)(再鼎医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -0.14-0.05-0.35-0.25-0.18-0.05-0.46-0.40-0.23-0.09
 每股净资产(元) 7.077.688.198.919.4810.2310.6811.2912.3813.67
 每股经营现金净流量(元) -1.33-0.91-2.04-1.85-1.30-0.71-3.75-2.64-1.35-0.91
 每股现金流量净额(元) -0.60-0.40-2.24-2.21-1.51-1.310.451.59-2.89-1.22
 每股营业收入(元) 1.880.882.742.031.340.642.201.560.970.49
盈利能力:
 销售毛利率(%) 63.3161.4264.0864.8765.7566.0265.5865.1765.1766.52
 销售净利率(%) -71.27-61.36-125.46-119.07-129.15-78.26-206.14-250.28-232.17-176.34
 净资产收益率平均(%) -17.83-6.86-36.34-24.83-17.19-4.80-36.55-30.70-17.00-6.13
 总资产净利率(%) -13.22-5.28-29.66-21.13-14.62-4.11-31.33-26.23-14.55-5.30
 投入资本回报率ROIC(%) -44.33-18.32-146.18-102.53-74.11-19.58-103.39-92.50-31.84-12.68
收益质量:
 营业利润/利润总额(%) 109.44131.49109.55101.4293.52141.4791.2280.4981.0196.81
 经营活动产生的现金流量净额/营业收入(%) -70.49-103.39-74.30-91.23-97.21-110.33-170.96-169.48-139.12-186.47
资本结构:
 资产负债率(%) 28.6822.8923.1815.5915.7314.4314.3114.8414.5612.85
 权益乘数 1.401.301.301.181.191.171.171.171.171.15
 产权比率 0.400.300.300.180.190.170.170.170.170.15
 流动资产/总资产(%) 88.1189.9090.6791.9691.9791.6492.1593.1794.1492.83
 非流动资产/总资产(%) 11.8910.109.338.048.038.367.856.835.867.17
 流动负债/负债合计(%) 88.8984.9084.5576.7676.6173.7880.1280.7481.7480.30
 非流动负债/负债合计(%) 11.1115.1015.4523.2423.3926.2219.8819.2618.2619.70
 归属母公司股东的权益/投入资本(%) 197.07225.72323.44345.63377.12344.98493.97617.67164.26200.01
偿债能力:
 流动比率 3.464.634.637.687.638.618.047.787.918.99
 速动比率 3.294.434.417.337.368.307.817.597.778.86
 货币资金/流动负债(%) 250.30338.76389.11631.57644.27706.36721.15719.70403.15546.73
 营业利润/流动负债(%) -58.15-36.60-180.52-194.24-119.25-55.81-289.15-197.41-105.69-51.49
 经营活动产生的现金流量净额/流动负债(%) -52.55-46.90-97.59-146.73-95.98-55.63-262.90-166.09-78.18-56.24
 归属母公司股东的权益/负债合计(%) 248.66336.84331.47541.42535.63593.04599.04574.05586.69678.05
 经营活动产生的现金流量净额/负债合计(%) -46.71-39.82-82.51-112.63-73.53-41.04-210.63-134.11-63.90-45.17
 营业利润/负债合计(%) -51.69-31.07-152.63-149.09-91.36-41.18-231.66-159.39-86.38-41.35
成长能力:
 总资产同比增长率(%) -10.76-15.52-15.07-19.62-22.02-22.04-24.21-24.86-25.1432.67
 每股净资产同比增长率(%) -25.39-24.88-23.32-21.09-23.46-25.21-25.39-32.23-29.8219.87
 总负债同比增长率(%) 62.7034.0237.60-15.54-15.76-12.48-24.1137.46-7.5658.61
 基本每股收益同比增长率(%) 22.22-23.9137.5021.7444.4439.4724.5347.7365.38
 归属母公司股东的权益同比增长率(%) -24.47-23.88-23.86-20.34-23.09-23.45-24.23-30.36-27.4929.55
 营业利润同比增长率(%) 7.95-1.139.3421.0010.9012.8442.2436.1455.1264.88
 营业收入同比增长率(%) 42.5338.7824.0331.7838.7434.4049.0152.2266.38132.42
 股东权益合计同比增长率(%) -24.47-23.88-23.86-20.34-23.09-23.45-24.23-30.36-27.4929.55
营运能力:
 存货周转率次(次) 1.590.812.511.861.330.612.932.211.560.80
 流动资产周转率次(次) 0.210.100.260.190.120.060.160.110.070.03
 固定资产周转率次(次) 3.601.644.783.552.301.084.263.262.121.06
 总资产周转率次(次) 0.190.090.240.180.110.050.150.100.060.03
衍生指标:
 现金及现金等价物净增加额TTM(元) -129,782,000.00-128,953,000.00-218,009,000.00-329,681,000.00179,323,000.0033,087,000.0044,370,000.00-278,962,000.00-1,085,693,000.00-166,403,000.00
 利润总额TTM(元) -298,329,000.00-338,947,000.00-334,620,000.00-300,960,000.00-392,998,000.00-410,036,000.00-443,286,000.00-593,342,000.00-528,564,000.00-553,955,000.00
 毛利TTM(元) 203,143,000.00182,973,000.00170,903,000.00171,987,000.00165,734,000.00151,401,000.00141,022,000.00121,812,000.00115,257,000.00110,556,000.00
 投入资本(元) 357,320,000.00337,657,000.00246,144,000.00254,888,000.00247,218,000.00290,230,000.00211,670,000.00179,038,000.00737,957,000.00653,958,000.00
 经营活动产生的现金流量净额TTM(元) -202,468,000.00-218,997,000.00-198,178,000.00-292,553,000.00-363,604,000.00-349,802,000.00-367,642,000.00-411,344,000.00-445,910,000.00-466,858,000.00
 总营业收入TTM(元) 322,711,000.00291,071,000.00266,719,000.00263,490,000.00251,801,000.00231,113,000.00215,040,000.00196,610,000.00182,174,000.00170,933,000.00
 归属母公司净利润TTM(元) -298,329,000.00-338,947,000.00-334,620,000.00-300,960,000.00-392,998,000.00-410,036,000.00-443,286,000.00-593,342,000.00-528,564,000.00-553,955,000.00

前瞻产业研究院